⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for p38 map kinase

Every month we try and update this database with for p38 map kinase cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaNCT00087867
Multiple Myelom...
SCIO-469
SCIO-469 and bo...
18 Years - Scios, Inc.
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.NCT00113893
Bone Marrow Dis...
Myelodysplastic...
Hematologic Dis...
Bone Marrow Neo...
SCIO-469
SCIO-469
SCIO-469
SCIO-469
18 Years - Scios, Inc.
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaNCT00095680
Multiple Myelom...
SCIO-469
SCIO-469 and bo...
18 Years - Scios, Inc.
A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE InhibitorsNCT02322853
Postmenopausal
Metastatic Brea...
Tamoxifen
Ralimetinib (LY...
18 Years - Centre Francois Baclesse
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: